Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Eijkman Oxford Clinical Research Unit in Indonesia and Sumba Foundation collaborated with photographer Yoppy Pieter to express the human face of leprosy in Sumba, a remote island in eastern Indonesia. The project aimed to visualize the story of leprosy and raise awareness of this debilitating and heavily stigmatised disease

Leprosy patient showing hypopigmented skin lesions with loss of sensation © 2022 Elsevier Ltd
Agustinus developed six hypopigmented skin lesions with loss of sensation in the past five years. The lesions started on his chin and slowly extended to his arms and legs. He was diagnosed with multibacillary leprosy a year ago. In endemic settings, leprosy is diagnosed on the basis of the presence of at least one out of three cardinal signs: the presence of skin lesions with definite loss of sensation, a thickened or enlarged peripheral nerve, and a positive slit­ skin smear (or skin/nerve biopsy) with the demonstration of mycobacteria.

Leprosy impacts impoverished communities in low-income and middle-income countries (LMICs), with over 200,000 new cases recorded annually worldwide. This infectious disease is caused by Mycobacterium leprae or Mycobacterium lepromatosis and primarily affects the skin and peripheral nerves. Effective multidrug therapy is available, and, with early detection and treatment, leprosy is curable. Yet disease management can be complicated by immune-mediated reactions, which may cause irreversible nerve damage and lead to lifelong disabilities that are associated with stigmatisation and discrimination. Despite progress in the past few decades, the disease burden has stalled, with some countries not meeting WHO goals of interrupting transmission and reducing incidence.

The Eijkman Oxford Clinical Research Unit (EOCRU) in Indonesia and Sumba Foundation collaborated with photographer Yoppy Pieter to express the human face of leprosy in Sumba, a remote island in eastern Indonesia. The project aimed to visualise the story of leprosy and raise awareness of this debilitating and heavily stigmatised disease.

This photo is a part of the series “Picturing health: the burden of leprosy in eastern Indonesia” on The Lancet website

The full story is available on the OUCRU website

 

 

Similar stories

Dengue Research Article Awarded The 2021 – 2022 Alexandre Yersin Prize for Outstanding Publications

OUCRU research article titled ‘Combination of inflammatory and vascular markers in the febrile phase of dengue is associated with more severe outcomes’ was recently awarded the 2021-2022 Alexandre Yersin Prize for Outstanding Publications.

OUCRU SPEAR Digital Diaries

Healthcare workers and community members in Indonesia, Nepal and Vietnam have been documenting their personal experiences of Covid-19. They have each made their own ‘digital diary’, using a range of creative tools and with technical support from the project team. These diaries form part of the SPEAR project: exploring the experiences and impacts of COVID-19 for healthcare workers and vulnerable communities.

Clinical trials for a malaria vaccine start in Mali and Indonesia

Sanaria Inc. announced that two new Phase 2 trials of its pioneering malaria vaccines have started. The first is in 6- to 10-year-old children living in Bancoumana, Mali, a malarious region of West Africa. The second is in Indonesian soldiers based in Sumatra, Indonesia. The soldiers will be deploying for six to nine months this coming August to an intensely malarious district in eastern Indonesia.

Taking relationships seriously

Community Engagement (CE) is a critical aspect of health research because of its potential to make research more ethical, relevant, and well implemented. Many research programmes now aim to incorporate CE activities at all stages of their work. This KWTRP brief summarises key findings from a malaria trials, and provides an illustration of how CE works more generally. It highlights facilitators and challenges to engagement, and the ethical issues that are particularly relevant in LMIC settings with under resourced health systems.

Congratulations to our new Associate Professors

Our heartfelt congratulations to Melissa Kapulu, Francis Ndungu and Emelda Okiro from KWTRP, and to Hoa Thi Ngo and Sophie Yacoub from OUCRU who have been awarded Associate Professorships

First-of-its-kind study found equine antitoxin is safe and effective for the treatment of tetanus in adults

A first-of-its kind randomised controlled trial compared two different antitoxin treatments for tetanus. A comparison of human and equine intramuscular antitoxin in adults found that intramuscular equine antitoxin is safe and effective for treating tetanus in adults. Addition of additional intrathecal (spinal) antitoxin does not add any benefit compared to treatment with intramuscular antitoxin alone.